215 related articles for article (PubMed ID: 33668571)
1. Steroid Eluting Esophageal-Targeted Drug Delivery Devices for Treatment of Eosinophilic Esophagitis.
Prasher A; Shrivastava R; Dahl D; Sharma-Huynh P; Maturavongsadit P; Pridgen T; Schorzman A; Zamboni W; Ban J; Blikslager A; Dellon ES; Benhabbour SR
Polymers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668571
[TBL] [Abstract][Full Text] [Related]
2. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
3. Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis.
Kruszewski PG; Russo JM; Franciosi JP; Varni JW; Platts-Mills TA; Erwin EA
Dis Esophagus; 2016 May; 29(4):377-84. PubMed ID: 25721813
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis.
Kia L; Nelson M; Zalewski A; Gregory D; Gonsalves N; Straumann A; Hirano I
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 30380044
[TBL] [Abstract][Full Text] [Related]
5. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.
Miehlke S; Lucendo AJ; Straumann A; Jan Bredenoord A; Attwood S
Therap Adv Gastroenterol; 2020; 13():1756284820927282. PubMed ID: 32565912
[TBL] [Abstract][Full Text] [Related]
6. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.
Nennstiel S; Schlag C
World J Gastroenterol; 2020 Sep; 26(36):5395-5407. PubMed ID: 33024392
[TBL] [Abstract][Full Text] [Related]
7. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.
Peterson KA; Thomas KL; Hilden K; Emerson LL; Wills JC; Fang JC
Dig Dis Sci; 2010 May; 55(5):1313-9. PubMed ID: 19533356
[TBL] [Abstract][Full Text] [Related]
8. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
10. Recent insights on the use of topical steroids in eosinophilic esophagitis.
Reddy A; Ashat D; Murali AR
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
von Arnim U; Malfertheiner P
Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
[TBL] [Abstract][Full Text] [Related]
12. Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis.
Syverson EP; Hait E
Gastroenterol Hepatol (N Y); 2022 Apr; 18(4):207-212. PubMed ID: 35505944
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
[TBL] [Abstract][Full Text] [Related]
14. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.
Lucendo AJ; De Rezende LC; Jiménez-Contreras S; Yagüe-Compadre JL; González-Cervera J; Mota-Huertas T; Guagnozzi D; Angueira T; González-Castillo S; Arias A
Dig Dis Sci; 2011 Dec; 56(12):3551-8. PubMed ID: 21674173
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.
Kavitt RT; Penson DF; Vaezi MF
Dis Esophagus; 2014 Jul; 27(5):418-23. PubMed ID: 22947137
[TBL] [Abstract][Full Text] [Related]
16. Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity.
van Rhijn BD; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
Am J Gastroenterol; 2015 Sep; 110(9):1289-97. PubMed ID: 26303134
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
[TBL] [Abstract][Full Text] [Related]
19. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?
Walgraeve S; Vanuytsel T
Acta Gastroenterol Belg; 2023; 86(3):437-448. PubMed ID: 37814560
[TBL] [Abstract][Full Text] [Related]
20. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
